PNEUMOCONIOSIS

Clinical trials for PNEUMOCONIOSIS explained in plain language.

Never miss a new study

Get alerted when new PNEUMOCONIOSIS trials appear

Sign up with your email to follow new studies for PNEUMOCONIOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for black lung? drug trial targets scarred lungs

Disease control Recruiting now

This study tests if pirfenidone capsules can help people with pneumoconiosis, a lung disease caused by inhaling dust like coal or silica. About 272 adults with silicosis or coal worker's pneumoconiosis will receive either the drug or a placebo for 52 weeks. The main goal is to se…

Matched conditions: PNEUMOCONIOSIS

Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control

Last updated May 26, 2026 09:37 UTC

PNEUMOCONIOSIS

Get alerted when new PNEUMOCONIOSIS trials appear

New hope for black lung? drug trial targets scarred lungs